. . . . . . . "[Previous studies suggest that tazarotene, a new member of the acetylenic class of RAR?/? selective retinoids which is approved to treat a variety of skin diseases, exhibits an anti-proliferative effect in human basal cell carcinoma (BCC) by triggering caspase-dependent apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:15:54+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .